Arbutus falls as patent dispute with Moderna hits EU snag

Arbutus (ABUS) stock sinks as the European Patent Office revokes a patent that was subject to a legal dispute between the ...
Investing.com India

Arbutus stock falls after European patent revoked

Investing.com -- Arbutus Biopharma Corporation stock fell 7% on Friday following news that the Board of Appeal of the ...

Arbutus Biopharma Falls on Revocation of European Patent

Shares of Arbutus Biopharma slid after the company said the European Patent Office had revoked one of its patents. The stock slipped 12%, to $4.15, midday Friday, but has gained 29% in the past year.
FiercePharma

Moderna nabs a win in Arbutus patent case as appeals court upholds prior invalidation

While Arbutus Biopharma is busy scrapping with Moderna and Pfizer over COVID-19 vaccine patents, Moderna has chalked up a win in a separate case. Back in 2018, Moderna challenged one of Arbutus’ lipid ...
Yahoo Finance

Here’s Why Arbutus (ABUS) Surged in Q3

Tourlite Capital Management, an investment management firm, released its third quarter 2024 investor letter, a copy of which can be downloaded here. Tourlite Fund, LP Founder Class returned 4.5% for ...